Your search returned 2 results.

Results
	1.	Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins. [electronic resource] by Dwojak, M Bobrowicz, M Bil, J Bojarczuk, K Pyrzynska, B Siernicka, M Malenda, A Lech-Maranda, E Tomczak, W Giannopoulos, K Golab, J Winiarska, M Producer: 20150916 In: Blood cancer journal vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies. [electronic resource] by Bojarczuk, K Siernicka, M Dwojak, M Bobrowicz, M Pyrzynska, B Gaj, P Karp, M Giannopoulos, K Efremov, D G Fauriat, C Golab, J Winiarska, M Producer: 20140710 In: Leukemia vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search